{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:28:48Z","timestamp":1787239728116,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12276-5","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:17:06Z","timestamp":1764782226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genotypic spectrum and prevalence of HPV associated with cervical cancer in Palestine"],"prefix":"10.1186","volume":"26","author":[{"given":"Ibrahim","family":"Salhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alzahayqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Qrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarteel","family":"Qawasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Qadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaidoun","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"12276_CR1","unstructured":"World Health O. Cervical Cancer. 2023."},{"key":"12276_CR2","unstructured":"World Health O. Human papillomavirus (HPV). World Health Organization, Regional Office for Europe; 2017."},{"issue":"1","key":"12276_CR3","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman M, et al. Carcinogenic human papillomavirus infection. Nat Reviews Disease Primers. 2016;2(1):16086.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"12276_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1186\/s12879-024-10203-8","volume":"24","author":"I Salhi","year":"2024","unstructured":"Salhi I, Salah Z, Qadi M. Prevalence, genotyping and phylogenetic analysis of HPV infecting Palestinian women. BMC Infect Dis. 2024;24(1):1299.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"12276_CR5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jiph.2020.06.012","volume":"13","author":"DA Obeid","year":"2020","unstructured":"Obeid DA, et al. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the middle East and North africa: A systematic review and meta-analysis. J Infect Public Health. 2020;13(9):1304\u201313.","journal-title":"J Infect Public Health"},{"issue":"1","key":"12276_CR6","doi-asserted-by":"publisher","first-page":"e0169197","DOI":"10.1371\/journal.pone.0169197","volume":"12","author":"AA Elmi","year":"2017","unstructured":"Elmi AA, et al. Human papillomavirus (HPV) infection: molecular epidemiology, genotyping, seroprevalence and associated risk factors among Arab women in Qatar. PLoS One. 2017;12(1):e0169197.","journal-title":"PLoS ONE"},{"key":"12276_CR7","doi-asserted-by":"crossref","unstructured":"AlWaheidi S, et al. Mammographic screening in the occupied Palestinian territory: a critical analysis of its promotion, claimed benefits, and safety in Palestinian health research. JCO Glob Oncol. 2020;6:1772\u201390.","DOI":"10.1200\/JGO.19.00383"},{"issue":"1","key":"12276_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1472-6890-14-30","volume":"14","author":"AN Snow","year":"2014","unstructured":"Snow AN, et al. A simple and cost-effective method of DNA extraction from small formalin-fixed paraffin-embedded tissue for molecular oncologic testing. BMC Clin Pathol. 2014;14(1):30.","journal-title":"BMC Clin Pathol"},{"issue":"1","key":"12276_CR9","doi-asserted-by":"publisher","first-page":"bpac014","DOI":"10.1093\/biomethods\/bpac014","volume":"7","author":"U Oba","year":"2022","unstructured":"Oba U, et al. An efficient procedure for the recovery of DNA from formalin-fixed paraffin-embedded tissue sections. Biology Methods Protocols. 2022;7(1):bpac014.","journal-title":"Biology Methods Protocols"},{"issue":"2","key":"12276_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0166-0934(03)00109-5","volume":"110","author":"O Forslund","year":"2003","unstructured":"Forslund O, Ly H, Higgins G. Improved detection of cutaneous human papillomavirus DNA by single tube nested \u2018hanging droplet\u2019 PCR. J Virol Methods. 2003;110(2):129\u201336.","journal-title":"J Virol Methods"},{"issue":"2","key":"12276_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0166-0934(97)00056-6","volume":"66","author":"C Mant","year":"1997","unstructured":"Mant C, et al. Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types \u2013\u20096, -11, -16, -18, -31 and \u2013\u200933. J Virol Methods. 1997;66(2):169\u201378.","journal-title":"J Virol Methods"},{"issue":"1","key":"12276_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yexmp.2015.11.024","volume":"100","author":"SMM Erhart","year":"2016","unstructured":"Erhart SMM, et al. Comparative evaluation of the GP5+\/6+, MY09\/11 and PGMY09\/11 primer sets for HPV detection by PCR in oral squamous cell carcinomas. Exp Mol Pathol. 2016;100(1):13\u20136.","journal-title":"Exp Mol Pathol"},{"key":"12276_CR13","doi-asserted-by":"publisher","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","volume":"144","author":"L Bruni","year":"2021","unstructured":"Bruni L, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of National HPV immunization coverage 2010\u20132019. Prev Med. 2021;144:106399.","journal-title":"Prev Med"},{"issue":"7","key":"12276_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"key":"12276_CR15","unstructured":"World Health O. Human papillomavirus (HPV) and cancer. World Health Organization; 2024."},{"issue":"7","key":"12276_CR16","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","volume":"4","author":"L Bruni","year":"2016","unstructured":"Bruni L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453\u201363.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"12276_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"13","key":"12276_CR18","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","volume":"51","author":"B Serrano","year":"2015","unstructured":"Serrano B, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51(13):1732\u201341.","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"12276_CR19","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1016\/j.vaccine.2013.10.001","volume":"31","author":"FX Bosch","year":"2013","unstructured":"Bosch FX, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31(Suppl 5):F1\u201331.","journal-title":"Vaccine"},{"key":"12276_CR20","doi-asserted-by":"crossref","unstructured":"Castle PE, Giuliano AR. Chap. 4: Genital tract infections, cervical inflammation, and antioxidant nutrients\u2013assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr. 2003(31):29\u201334.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003478"},{"issue":"5","key":"12276_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/djq001","volume":"102","author":"AC Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez AC, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315\u201324.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"12276_CR22","doi-asserted-by":"publisher","first-page":"e2641","DOI":"10.1016\/j.ajog.2016.10.042","volume":"216","author":"K Elfgren","year":"2017","unstructured":"Elfgren K, et al. Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial. Am J Obstet Gynecol. 2017;216(3):e2641\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"12276_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, et al. Human papillomavirus testing in the prevention of cervical cancer. JNCI: J Natl Cancer Inst. 2011;103(5):368\u201383.","journal-title":"JNCI: J Natl Cancer Inst"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12276-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:57:46Z","timestamp":1767790666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12276"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12276-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board (IRB) at An-Najah National University (Ref: MAS. OCT. 2023\/6). The research followed all relevant ethical guidelines and regulations and comes in compliance with Helsinki declaration. Participants were informed about the research objectives and provided consent either through direct telephone communication or via the histopathology laboratories holding their archived samples. Each participant was individually informed of their test results. All participant information and samples were securely managed and anonymized, with access limited exclusively to authorized research personnel.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from each participant after clearly explaining the purpose and scope of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}